ema semaglutide naion label update 2025 linked to increased risk of vision loss in diabetes patients GLP-1 Receptor Agonists and vision

Those who have successfully implemented sustainable changesincluding regular physical activity (UK Chief Medical Officers recommend at least 150 minutes of moderate-intensity activity weekly), improved dietary patterns, and behavioural strategies for weight managementmay have better outcomes if discontinuing GLP-1 therapy

Exenatide and liraglutide demonstrated the decrease of all-cause mortality, blood pressure values, weight reduction and improvement of dyslipidemia

Key Takeaway Starting point matters significantly

The people who succeed on tirzepatide are the ones who spend two hours on Sunday preparing the week's meals so that eating well requires zero decision-making during the week

L.WaggonerD.GitlinJ

B-12/MIC injections are prescribed and administered under provider supervision as part of an individualized wellness plan